{"id":7133,"date":"2024-10-18T14:31:00","date_gmt":"2024-10-18T09:01:00","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=7133"},"modified":"2024-10-18T14:47:13","modified_gmt":"2024-10-18T09:17:13","slug":"schizophrenia-versus-bipolar-disorder","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder","title":{"rendered":"Schizophrenia vs Bipolar disorder: Biomarkers to the rescue"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a00705eb96a8\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a00705eb96a8\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder\/#Why_is_the_distinction_important\" >Why is the distinction important?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder\/#Key_Differences_Between_Schizophrenia_and_Bipolar_Disorder\" >Key Differences Between Schizophrenia and Bipolar Disorder<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder\/#Genetic_and_Biological_Overlap\" >Genetic and Biological Overlap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder\/#Importance_of_Accurate_Diagnosis\" >Importance of Accurate Diagnosis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder\/#The_Role_of_Biomarkers\" >The Role of Biomarkers<\/a><\/li><\/ul><\/nav><\/div>\n\n<p>Schizophrenia and Bipolar Disorder are often challenging to differentiate due to their overlapping symptoms. <a href=\"https:\/\/www.delveinsight.com\/report-store\/schizophrenia-market\"><strong>Schizophrenia<\/strong><\/a> is primarily marked by hallucinations and delusions, leading individuals to lose touch with reality. Patients may hear voices or see things that aren\u2019t there, creating a profound sense of detachment from the world around them. This condition is classified as a psychotic disorder, where the mind struggles to discern what is real from what is imagined. In contrast, <strong>Bipolar Disorder<\/strong> is characterized by extreme mood swings that can range from deep depression to manic highs. During manic episodes, individuals may experience heightened energy, euphoria, or irritability, while depressive phases bring overwhelming sadness and hopelessness. Though primarily recognized as a mood disorder, bipolar disorder can also involve episodes of psychosis, blurring the lines between these two complex conditions.<\/p>\n\n\n\n<p>While both disorders feature elements of psychosis, their underlying mechanisms and manifestations are distinct. Understanding these differences is crucial for accurate diagnosis and effective treatment, ensuring that individuals receive the care they need to navigate their unique mental health journeys.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-why-is-the-distinction-important\"><span class=\"ez-toc-section\" id=\"Why_is_the_distinction_important\"><\/span><strong>Why is the distinction important?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Understanding the distinction between <strong>schizophrenia<\/strong> and <a href=\"https:\/\/www.delveinsight.com\/report-store\/bipolar-disorder-manic-depression-market\"><strong>bipolar disorder<\/strong><\/a> is crucial for accurate diagnosis and effective treatment. While both are serious mental health conditions that can drastically impact a person\u2019s life, they manifest with distinct characteristics, symptoms, and approaches to care. Misdiagnosis between the two can lead to inappropriate treatments that exacerbate symptoms or lead to complications, making early detection vital for ensuring patients receive the right care.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Differences_Between_Schizophrenia_and_Bipolar_Disorder\"><\/span><strong>Key Differences Between Schizophrenia and Bipolar Disorder<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Nature of Symptoms<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Bipolar Disorder<\/strong> is characterized by extreme mood swings, including episodes of mania (or hypomania) and depression. During manic episodes, individuals experience euphoria, high energy, risky behaviors, and racing thoughts. In contrast, depressive episodes are marked by deep sadness, hopelessness, and a lack of interest in activities.<\/li>\n\n\n\n<li><strong>Schizophrenia<\/strong>, on the other hand, is primarily defined by psychotic symptoms such as hallucinations , delusions , disorganized thinking, and negative symptoms like emotional flatness and social withdrawal. These symptoms create a profound disconnect from reality, significantly impacting daily functioning.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Mood Stability<\/strong>\n<ul class=\"wp-block-list\">\n<li>In <strong>Bipolar Disorder<\/strong>, mood swings are often followed by periods of stability. These intervals, which can last for days, weeks, or even months, allow individuals to function normally without significant mood disturbances.<\/li>\n\n\n\n<li>For those with <strong>schizophrenia<\/strong>, symptoms tend to persist and continuously interfere with daily life. While periods of remission may occur, ongoing management of the condition is generally required due to its chronic nature.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Psychotic Features<\/strong>\n<ul class=\"wp-block-list\">\n<li><strong>Bipolar Disorder<\/strong> may involve psychotic symptoms like hallucinations or delusions during severe episodes of mania or depression. However, these psychotic features are typically tied to the individual&#8217;s mood state and are not always present.<\/li>\n\n\n\n<li><strong>Schizophrenia<\/strong> is defined by psychotic symptoms that can occur independently of mood fluctuations. These symptoms are central to the diagnosis and persist even outside of mood episodes.<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Genetic_and_Biological_Overlap\"><\/span><strong>Genetic and Biological Overlap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Research has revealed that <strong>schizophrenia<\/strong> and <strong>bipolar disorder<\/strong> share genetic underpinnings. Studies show that certain genetic mutations associated with schizophrenia are also found in individuals experiencing mania. Developmental risk factors and overlapping gene loci, including three major gene regions of interest, further suggest a shared genetic history. Despite this genetic overlap, important biological distinctions exist between the two disorders. For example, <strong>MRI<\/strong> scans show differences in gray matter volume, cortical and subcortical regions, the insula, and the thalamus between schizophrenia and bipolar disorder patients.<\/p>\n\n\n\n<p>These biological differences contribute to the diagnostic challenges clinicians face, with some studies presenting contradictory results. Misdiagnosis remains a significant issue, underscoring the importance of early and accurate diagnosis for ensuring effective treatment.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Importance_of_Accurate_Diagnosis\"><\/span><strong>Importance of Accurate Diagnosis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Diagnosing <strong>schizophrenia<\/strong> or <strong>bipolar disorder<\/strong> accurately is essential for several reasons:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Treatment Approaches<\/strong>: Treatment for <strong>bipolar disorder<\/strong> often involves mood stabilizers and psychotherapy, while <strong>schizophrenia<\/strong> typically requires <strong>antipsychotic medications<\/strong> in combination with supportive therapies. Misdiagnosis can lead to ineffective treatment regimens, potentially worsening the patient&#8217;s condition.<\/li>\n\n\n\n<li><strong>Prognosis and Management<\/strong>: Determining whether a patient has <strong>schizophrenia<\/strong> or <strong>bipolar disorder<\/strong> affects their long-term prognosis and the type of care they need. <strong>Bipolar disorder<\/strong> is generally more manageable with appropriate treatment, while <strong>schizophrenia<\/strong> often demands more intensive intervention and support.<\/li>\n\n\n\n<li><strong>Impact on Daily Life<\/strong>: Both disorders disrupt daily functioning but in different ways. Individuals with <strong>bipolar disorder<\/strong> may struggle with relationships due to mood swings, whereas those with <strong>schizophrenia<\/strong> face challenges related to reality perception and social interactions due to their psychotic symptoms.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-the-role-of-biomarkers\"><span class=\"ez-toc-section\" id=\"The_Role_of_Biomarkers\"><\/span><strong>The Role of Biomarkers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><strong>Biomarkers<\/strong> are emerging as a vital tool in identifying the risk of <a href=\"https:\/\/www.delveinsight.com\/report-store\/schizophrenia-epidemiology-forecast\"><strong>schizophrenia<\/strong><\/a>, predicting its progression, and aiding in diagnosis and treatment. These markers, whether molecular (like DNA or proteins) or macroscopic (such as brain imaging), provide clinicians with deeper insights into the disorder&#8217;s onset and trajectory. This enables more targeted approaches to treatment, optimizing the use of <strong>schizophrenia medications<\/strong>.<\/p>\n\n\n\n<p>One promising area of biomarker research involves <strong>neuroimaging<\/strong>, which can capture phenotypic variations in brain circuits, as well as molecular and cellular disease targets. Potential biomarkers identified through neuroimaging include <strong>dopamine hyperactivity<\/strong>, <strong>hippocampal hyperactivity<\/strong>, and <strong>cortical gray matter volume loss<\/strong>. These biomarkers could help clinicians tailor specific medications for schizophrenia based on individual brain changes. Another marker, the <strong>auditory steady-state response (ASSR)<\/strong>, has been explored for its role in auditory processing, showing potential as an indicator for schizophrenia and other psychiatric conditions.<\/p>\n\n\n\n<p>On a molecular level, nutrient deficiencies, such as low <strong>Vitamin B6<\/strong> levels, have been associated with a higher risk of schizophrenia. Additionally, elevated levels of the <strong>G72 protein<\/strong> have been found in those with the disorder, making it a key biomarker to monitor. <strong>Peripheral epigenetic markers<\/strong>, including DNA methylation and miRNA expression patterns, also reveal significant differences between individuals with schizophrenia and healthy controls. Furthermore, increased <strong>inflammatory markers<\/strong> in maternal blood during pregnancy have been linked to a heightened risk of developing schizophrenia, highlighting the complex interplay between genetic and environmental factors in the condition.<\/p>\n\n\n\n<p>Adding to this growing body of research, a study published in the <em>Journal of Psychiatric Research<\/em> shed light on the role of <strong>blood serum metabolomics<\/strong> in distinguishing between different psychiatric disorders, including <strong>schizophrenia<\/strong> and <strong>bipolar disorder<\/strong>. In this study, blood serum samples from 54 schizophrenia patients, 68 bipolar disorder patients, and 60 healthy volunteers were analyzed using <strong>proton nuclear magnetic resonance (NMR) spectroscopy<\/strong>. The results showed distinct chemical differences between the two disorders, further demonstrating the potential of biomarkers to enhance the accuracy of psychiatric diagnoses.<\/p>\n\n\n\n<p>However, the study also faced limitations, such as a small patient pool, variations in ethnicity, and differences in medications among participants. These factors could have influenced the findings, underscoring the need for further research to validate and expand upon these results.<\/p>\n\n\n\n<p>As advancements in biomarker research continue, the future of schizophrenia treatment looks promising. These biomarkers could help clinicians predict which <strong>schizophrenia medications<\/strong> will be most effective for individual patients, leading to more personalized and effective treatment strategies. With ongoing research into novel therapies targeting neuroplasticity and inflammation, the integration of biomarkers into schizophrenia care could revolutionize the field, transforming both diagnostic approaches and treatment outcomes.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.delveinsight.com\/report-store\/schizophrenia-market\"><img decoding=\"async\" width=\"1024\" height=\"194\" src=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/10\/18140609\/Schizophrenia-Market-Outlook-8-1024x194.png\" alt=\"\" class=\"wp-image-30090\" srcset=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/10\/18140609\/Schizophrenia-Market-Outlook-8-1024x194.png 1024w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/10\/18140609\/Schizophrenia-Market-Outlook-8-300x57.png 300w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/10\/18140609\/Schizophrenia-Market-Outlook-8-150x28.png 150w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/10\/18140609\/Schizophrenia-Market-Outlook-8-768x145.png 768w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/10\/18140609\/Schizophrenia-Market-Outlook-8-1536x291.png 1536w, https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2024\/10\/18140609\/Schizophrenia-Market-Outlook-8.png 1584w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Schizophrenia and Bipolar Disorder are often challenging to differentiate due to their overlapping symptoms. Schizophrenia is primarily marked by hallucinations and delusions, leading individuals to lose touch with reality. Patients may hear voices or see things that aren\u2019t there, creating a profound sense of detachment from the world around them. This condition is classified as [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":30099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17,17434],"tags":[805,7335,7336,7361,7360,1519],"industry":[17225],"therapeutic_areas":[17245],"class_list":["post-7133","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-facts-and-figures","tag-biomarkers","tag-bipolar-disorder","tag-bipolar-disorder-market","tag-psychosis","tag-psychotic-disorder","tag-schizophrenia","industry-pharmaceutical","therapeutic_areas-neurology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Schizophrenia Versus Bipolar Disorder and the Role of Biomarkers<\/title>\n<meta name=\"description\" content=\"Schizophrenia is a condition when the brain of the patient fails to acknowledge what is real and what is not. It is a psychotic disorder...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Schizophrenia Versus Bipolar Disorder and the Role of Biomarkers\" \/>\n<meta property=\"og:description\" content=\"Schizophrenia is a condition when the brain of the patient fails to acknowledge what is real and what is not. It is a psychotic disorder...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-18T09:01:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-18T09:17:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/18144654\/Schizophrenia-vs-Bipolar-disorder-Biomarkers-to-the-rescue.png\" \/>\n\t<meta property=\"og:image:width\" content=\"466\" \/>\n\t<meta property=\"og:image:height\" content=\"284\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jatin Vimal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jatin Vimal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Schizophrenia Versus Bipolar Disorder and the Role of Biomarkers","description":"Schizophrenia is a condition when the brain of the patient fails to acknowledge what is real and what is not. It is a psychotic disorder...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder","og_locale":"en_US","og_type":"article","og_title":"Schizophrenia Versus Bipolar Disorder and the Role of Biomarkers","og_description":"Schizophrenia is a condition when the brain of the patient fails to acknowledge what is real and what is not. It is a psychotic disorder...","og_url":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2024-10-18T09:01:00+00:00","article_modified_time":"2024-10-18T09:17:13+00:00","og_image":[{"width":466,"height":284,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/18144654\/Schizophrenia-vs-Bipolar-disorder-Biomarkers-to-the-rescue.png","type":"image\/png"}],"author":"Jatin Vimal","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"Jatin Vimal","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder","url":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder","name":"Schizophrenia Versus Bipolar Disorder and the Role of Biomarkers","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/18144654\/Schizophrenia-vs-Bipolar-disorder-Biomarkers-to-the-rescue.png","datePublished":"2024-10-18T09:01:00+00:00","dateModified":"2024-10-18T09:17:13+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158"},"description":"Schizophrenia is a condition when the brain of the patient fails to acknowledge what is real and what is not. It is a psychotic disorder...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/schizophrenia-versus-bipolar-disorder#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/18144654\/Schizophrenia-vs-Bipolar-disorder-Biomarkers-to-the-rescue.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/18144654\/Schizophrenia-vs-Bipolar-disorder-Biomarkers-to-the-rescue.png","width":466,"height":284,"caption":"Schizophrenia vs Bipolar disorder Biomarkers to the rescue"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/c846f0323e948c55336d657b654f3158","name":"Jatin Vimal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/10dcf4b5071c366691525fa20af33b87e8a3897e6d0acc1a2b09a7b99b8d8ae1?s=96&d=mm&r=g","caption":"Jatin Vimal"},"sameAs":["https:\/\/www.delveinsight.com"]}]}},"author_meta":{"display_name":"Jatin Vimal","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/jatin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/12\/18144654\/Schizophrenia-vs-Bipolar-disorder-Biomarkers-to-the-rescue-300x183.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Facts and Figures<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>","<span class=\"advgb-post-tax-term\">Facts and Figures<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Biomarkers<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Bipolar disorder<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">Bipolar disorder market<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">psychosis<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">psychotic disorder<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/facts-and-figures\/\" class=\"advgb-post-tax-term\">schizophrenia<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Biomarkers<\/span>","<span class=\"advgb-post-tax-term\">Bipolar disorder<\/span>","<span class=\"advgb-post-tax-term\">Bipolar disorder market<\/span>","<span class=\"advgb-post-tax-term\">psychosis<\/span>","<span class=\"advgb-post-tax-term\">psychotic disorder<\/span>","<span class=\"advgb-post-tax-term\">schizophrenia<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on Oct 18, 2024","modified":"Updated on Oct 18, 2024"},"absolute_dates_time":{"created":"Posted on Oct 18, 2024 2:31 pm","modified":"Updated on Oct 18, 2024 2:47 pm"},"featured_img_caption":"Schizophrenia vs Bipolar disorder Biomarkers to the rescue","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=7133"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7133\/revisions"}],"predecessor-version":[{"id":30100,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/7133\/revisions\/30100"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/30099"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=7133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=7133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=7133"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=7133"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=7133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}